Varenicline: An α4β2 Nicotinic Receptor Partial Agonist for Smoking Cessation

Coe, Jotham W., Brooks, Paige R., Vetelino, Michael G., Wirtz, Michael C., Arnold, Eric P., Huang, Jianhua, Sands, Steven B., Davis, Thomas I. +13 more·2005·Journal of Medicinal Chemistry

Cited by (960)

Items 501–600 of 960

  1. Synthesis and biological evaluation of novel hybrids of highly potent and selective α4β2-Nicotinic acetylcholine receptor (nAChR) partial agonists
    Han-Kun Zhang, Jason Brek Eaton, Allison Fedolak, Hendra Gunosewoyo, Oluseye K. Onajole, Dani Brunner, Ronald J. Lukas, Li-Fang Yu, Alan P. Kozikowski · 2016 · European Journal of Medicinal Chemistry
  2. Therapeutic concentrations of varenicline in the presence of nicotine increase action potential firing in human adrenal chromaffin cells
    Arik J. Hone, J. Michael McIntosh, Lola Rueda‐Ruzafa, J. Passas, Cristina De Castro Guerín, Jesús Blázquez, Carmen González Enguita, Almudena Albillos · 2016 · Journal of Neurochemistry
  3. Synthesis of tetrahydro-3-benzazepines
    Meng‐Yang Chang, Chieh‐Kai Chan, Shin‐Ying Lin, Ru‐Ting Hsu · 2012 · Tetrahedron
  4. Methadone’s effect on nAChRs—a link between methadone use and smoking?
    Reeta Talka, Raimo K. Tuominen, Outi Salminen · 2015 · Biochemical Pharmacology
  5. Chapter 32 To Market, To Market – 2006
    Shridhar G. Hegde, Michelle A. Schmidt · 2007 · Annual reports in medicinal chemistry
  6. Synthesis and activity of substituted carbamates as potentiators of the α4β2 nicotinic acetylcholine receptor
    Stephanie K. Springer, Katrina S. Woodin, Virginia M. Berry, Alessandro A. Boezio, Lei Cao, Kristie Clarkin, Jean-Christophe Harmange, Markus Hierl, Johannes Knop, Annika B. Malmberg et al. · 2008 · Bioorganic & Medicinal Chemistry Letters
  7. Pharmacokinetics of cytisine after single intravenous and oral administration in rabbits
    Henri Angel Astroug, Rumyana Simeonova, L. Kassabova, N Danchev, Dobrin Avramov Svinarov · 2010 · Interdisciplinary Toxicology
  8. CNS Drug Development
    Sheldon Preskorn · 2014 · Journal of Psychiatric Practice
  9. Synthesis, Nicotinic Acetylcholine Receptor Binding, and Antinociceptive Properties of 2′-Fluoro-3′-(substituted pyridinyl)-7-deschloroepibatidine Analogues
    Pauline W. Ondachi, Ana H. Castro, Jakub Bartkowiak, Charles W. Luetje, Mohamad Imad Damaj, S. Wayne Mascarella, Hernán A. Navarro, Frank Ivy Carroll · 2014 · Journal of Medicinal Chemistry
  10. Improved treatment of nicotine addiction and emerging pulmonary drug delivery
    Islam · 2012 · Drug Discoveries & Therapeutics
  11. The 3,7-diazabicyclo[3.3.1]nonane scaffold for subtype selective nicotinic acetylcholine receptor (nAChR) ligands. Part 1: The influence of different hydrogen bond acceptor systems on alkyl and (hetero)aryl substituents
    Christoph Eibl, Isabelle Tomassoli, Lenka Munoz, Clare A. Stokes, Roger L. Papke, Daniela Gündisch · 2013 · Bioorganic & Medicinal Chemistry
  12. Secondary Ammonium Agonists Make Dual Cation-π Interactions in α4β2 Nicotinic Receptors
    Michael R. Post, Gabrielle S. Tender, Henry A. Lester, Dennis A. Dougherty · 2017 · eNeuro
  13. The effectiveness of Cytisine versus Nicotine Replacement Treatment for smoking cessation in the Russian Federation
    João Maurício Castaldelli-Maia, Silvia Saboia Martins, Natalie K. Walker · 2018 · International Journal of Drug Policy
  14. Cytisine versus varenicline for smoking cessation for Māori (the indigenous people of New Zealand) and their extended family: protocol for a randomized non‐inferiority trial
    Natalie K. Walker, Barry D. Smith, Joanne Barnes, Marjolein E. A. Verbiest, Tomasz Kurdziel, Varsha Parag, Subhash Pokhrel, Chris Bullen · 2018 · Addiction
  15. Revisiting autosomal dominant nocturnal frontal lobe epilepsy (ADNFLE) mutations in the nicotinic acetylcholine receptor reveal an increase in efficacy regardless of stochiometry
    Dinesh C. Indurthi, Taima Qudah, Vivian W. Y. Liao, Philip Kiær Ahring, T. Lewis, Thomas Balle, Mary Chebib, Nathan L. Absalom · 2018 · Pharmacological Research
  16. Varenicline aggravates atherosclerotic plaque formation in nicotine-pretreated ApoE knockout mice due to enhanced oxLDL uptake by macrophages through downregulation of ABCA1 and ABCG1 expression
    Mitsuhisa Koga, Yuki Kanaoka, Mana Okamoto, Yuki Nakao, Koshun Inada, Saki Takayama, Yasufumi Kataoka, Atsushi Yamauchi · 2019 · Journal of Pharmacological Sciences
  17. Effect of smoking cessation on sexual functions in men aged 30 to 60 years
    Mehmet Oğuz Şahin, Volkan Şen, Gazi Gündüz, Oktay Üçer · 2020 · International braz j urol
  18. Comparison of the effects of bupropion on nicotinic receptor-evoked [3H]dopamine release from rat striatal synaptosomes and slices
    Nimish Sidhpura, Peter H. Redfern, Susan Wonnacott · 2007 · European Journal of Pharmacology
  19. Varenicline: progress in smoking cessation treatment
    Elbert D. Glover, Jessica Miller Rath · 2007 · Expert Opinion on Pharmacotherapy
  20. ▼Varenicline for smoking cessation
    BMJ Publishing Group Ltd · 2008 · Drug and Therapeutics Bulletin
  21. Varenicline enhances recognition memory via α7 nicotinic acetylcholine receptors in the medial prefrontal cortex in male mice
    Hirohito Esaki, Satoshi Deyama, Shoma Izumi, Ayano Katsura, Keisuke Nishikawa, Naoya Nishitani, Katsuyuki Kaneda · 2023 · Neuropharmacology
  22. Cytisine for smoking cessation: A 40-day treatment with an induction period
    Biagio Tinghino, Salvatore Cardellicchio, Flavia Corso, Chiara Cresci, Victoria Pittelli, Rosastella Principe, Licia Siracusano, Giovanni Zelano, Vincenzo Zagà, Maria Sofia Cattaruzza · 2024 · Tobacco Prevention & Cessation
  23. Novel liquid chromatographic methods for the determination of varenicline tartrate
    Ramzia Ismail El-Bagary, Nisreen F. Abo-Talib, Marwa A. El-Wahab Mohamed · 2015 · Talanta
  24. Chemistry and Pharmacological Studies of 3-Alkoxy-2,5-Disubstituted-Pyridinyl Compounds as Novel Selective α4β2 Nicotinic Acetylcholine Receptor Ligands That Reduce Alcohol Intake in Rats
    Yong Liu, Janell R. Richardson, Thao Phuong Tran, Nour Al‐Muhtasib, Teresa Xie, Venkata Mahidhar Yenugonda, Hannah G. Sexton, Amir H. Rezvani, Edward D. Levin, Niaz Sahibzada et al. · 2013 · Journal of Medicinal Chemistry
  25. IUPHAR-review: The integration of classic psychedelics into current substance use disorder treatment models
    David B. Yaden, Andrea P. Berghella, Peter S. Hendricks, Mary Elizabeth Yaden, Michael Levine, Julia Sarah Rohde, Sandeep Manel Nayak, Matthew W. Johnson, Albert Garcia‐Romeu · 2023 · Pharmacological Research
  26. Administration of the nicotinic acetylcholine receptor agonists ABT-089 and ABT-107 attenuates the reinstatement of nicotine-seeking behavior in rats
    Alycia M. Lee, Adrian C. Arreola, Blake A. Kimmey, Heath D. Schmidt · 2014 · Behavioural Brain Research
  27. The safety of treatments for tobacco use disorder
    Melissa A. Little, Jon O. Ebbert · 2015 · Expert Opinion on Drug Safety
  28. Varenicline impairs extinction and enhances reinstatement across repeated cycles of nicotine self-administration in rats
    Claire L. Macnamara, Nathan M. Holmes, Reginald Frederick Westbrook, Kelly J. Clemens · 2016 · Neuropharmacology
  29. Pd-catalyzed arylation of linear and angular spirodiamine salts under aerobic conditions
    Sean W. Reilly, Nikaela W. Bryan, Robert H. Mach · 2016 · Tetrahedron Letters
  30. The nicotinic receptor drug sazetidine-A reduces alcohol consumption in mice without affecting concurrent nicotine consumption
    Jillienne C. Touchette, Jamie J Maertens, Margaret M Mason, Kyu Y. O’Rourke, Anna M. Lee · 2018 · Neuropharmacology
  31. Brain Nicotinic Receptors as Emerging Targets for Drug Addiction
    Shafiqur Rahman · 2011 · Progress in molecular biology and translational science
  32. New medications development for smoking cessation
    Dana Lengel, Paul J. Kenny · 2023 · Addiction Neuroscience
  33. How is Membrane Permeation of Small Ionizable Molecules Affected by Protonation Kinetics?
    Jonathan J. Harris, Christophe J. Chipot, Benoı̂t Roux · 2024 · The Journal of Physical Chemistry B
  34. Varenicline Reduces Alcohol Intake During Repeated Cycles of Alcohol Reaccess Following Deprivation in Alcohol‐Preferring (P) Rats
    Janice C. Froehlich, Emily R. Nicholson, Julian E. Dilley, Nick J. Filosa, Logan C. Rademacher, Teal N. Smith · 2017 · Alcoholism Clinical and Experimental Research
  35. Levo-tetrahydropalmatine inhibits α4β2 nicotinic receptor response to nicotine in cultured SH-EP1 cells
    Yuanbing Huang, Zegang Ma, Chao Jun Zheng, K. Xiao-kuang, Devin H. Taylor, Ming Gao, Ronald J. Lukas, Jie Wu · 2021 · Acta Pharmacologica Sinica
  36. Gestational ethanol exposure impairs motor skills in female mice through dysregulated striatal dopamine and acetylcholine function
    Sebastiano Bariselli, Yolanda Mateo, Noa Reuveni, David M. Lovinger · 2023 · Neuropsychopharmacology
  37. Stereoselective Synthesis and In Vivo Evaluation of the Analgesic Activity of Polysubstituted Bispidines
    Aurélie Plas, Fabien Marchand, Alain Eschalier, Yves Troin, Pierre Chalard · 2012 · European Journal of Organic Chemistry
  38. Depressive Symptoms Among Patients Receiving Varenicline and Bupropion for Smoking Cessation
    Arthur S. Hong, Muhamad Y. Elrashidi, Darrell R. Schroeder, Jon O. Ebbert · 2014 · Journal of Substance Abuse Treatment
  39. Preclinical and clinical research on the discriminative stimulus effects of nicotine
    Mohammed C. Shoaib, Kenneth A. Perkins · 2020 · Neuropharmacology
  40. Preventive effect of varenicline on impairment of endothelial function in cerebral vessels induced by acute smoking in rats
    Mami Iida, Hiroki Iida, Motoyasu Takenaka, Kumiko Tanabe, Kenji Iwata · 2012 · Journal of Anesthesia
  41. Pharmacokinetics of the Novel Nicotinic Receptor Antagonist N,N′-Dodecane-1,12-diyl-bis-3-picolinium Dibromide in the Rat
    Zaineb A.F. Albayati, Linda P. Dwoskin, Peter Anthony Crooks · 2008 · Drug Metabolism and Disposition
  42. miRNAome analysis of the mammalian neuronal nicotinic acetylcholine receptor gene family
    Eric M. Hogan, Alison P. Casserly, Michael D. Scofield, Zhongming Mou, Rubing Zhao-Shea, Chris W. Johnson, Andrew R. Tapper, Paul D Gardner · 2014 · RNA
  43. Pharmacological treatments for tobacco dependence
    K.O. Fagerström, Carlos Andrés Jimenez-Ruiz · 2008 · European Respiratory Review
  44. Inhibition of glycine transporter 1 attenuates nicotine- but not food-induced cue-potentiated reinstatement for a response previously paired with sucrose
    Jason M. Uslaner, Jason T. Drott, Steven S. Sharik, Cory R. Theberge, Cyrille Sur, Zhizhen Zeng, David L. Williams, Pete H. Hutson · 2009 · Behavioural Brain Research
  45. Discriminative Stimulus Properties of S(−)-Nicotine: “A Drug for All Seasons”
    John A. Rosecrans, Richard Young · 2017 · Current topics in behavioral neurosciences
  46. Varenicline Targets the Reinforcing-Enhancing Effect of Nicotine on Its Associated Salient Cue During Nicotine Self-administration in the Rat
    Vernon Garcia‐Rivas, Jean-François Fiancette, Nazzareno Cannella, María Carbo‐Gas, Prisca Renault, Jessica Tostain, Véronique Deroche‐Gamonet · 2019 · Frontiers in Behavioral Neuroscience
  47. Varenicline, the clinically effective smoking cessation agent, restores probabilistic response reversal performance during withdrawal from nicotine
    Anne E. Jackson, Sarah Silk, Yazead Buhidma, Mohammed C. Shoaib · 2016 · Addiction Biology
  48. Targeting Reward-Relevant Nicotinic Receptors in the Discovery of Novel Pharmacotherapeutic Agents to Treat Tobacco Dependence
    Linda P. Dwoskin, Marharyta Pivavarchyk, B. Matthew Joyce, Nichole M. Neugebauer‎, Guangrong Zheng, Zhenfa Zhang, Michael Thomas Bardo, Peter Anthony Crooks · 2008 · Nebraska Symposium on Motivation/The Nebraska symposium on motivation
  49. Evaluation of structurally diverse neuronal nicotinic receptor ligands for selectivity at the α6∗ subtype
    Scott R. Breining, Merouane Bencherif, Sharon R. Grady, Paul Whiteaker, Michael J. Marks, Charles R. Wageman, Henry A. Lester, Daniel Yohannes · 2009 · Bioorganic & Medicinal Chemistry Letters
  50. The effect of varenicline on heart rate variability in healthy smokers and nonsmokers
    Hasan Arı, Nuran Celiloğlu, Selma Arı, Selvi Coşar, Kubra Doğanay, Tahsin Bozat · 2011 · Autonomic Neuroscience
  51. Possible Involvement of Endogenous Opioid System Located Downstream of α7 Nicotinic Acetylcholine Receptor in Mice With Physical Dependence on Nicotine
    Keiko Ueno, Norikazu Kiguchi, Yuka Kobayashi, Fumihiro Saika, Naoki Wakida, Chizuko Yamamoto, Takehiko Maeda, Masanobu Ozaki, Shiroh Kishioka · 2013 · Journal of Pharmacological Sciences
  52. Electron ionization mass spectral study of selected N ‐amide and N ‐alkyl derivatives of cytisine
    Anna K. Przybył, Wiesław Prukała, Dariusz Kikut‐Ligaj · 2007 · Rapid Communications in Mass Spectrometry
  53. Pharmacological Effects of Nicotine on Norepinephrine Metabolism in Rat Brown Adipose Tissue: Relevance to Nicotinic Therapies for Smoking Cessation
    Dominique Brees, Michael R. Elwell, Francis David Tingley, Steven B. Sands, Amy B. Jakowski, Amy C. Shen, Jenny Cai, Martin B. Finkelstein · 2008 · Toxicologic Pathology
  54. Anxiety-depressive Symptoms in Patients with Chronic Obstructive Pulmonary Disease (COPD) and Impact on Outcome
    Osama M Gado Lamia A Basiony · 2015 · Journal of Depression & Anxiety
  55. Experimental studies of charge density distribution in the crystals of cytisine and N-methylcytisine. Inside the Fake Tobacco
    Agata Owczarzak, Anita M. Grześkiewicz, Maciej Kubicki · 2017 · Structural Chemistry
  56. Understanding the implications of the biobehavioral basis of nicotine addiction and its impact on the efficacy of treatment
    Nikki Bozinoff, Bernard Le Foll · 2018 · Expert Review of Respiratory Medicine
  57. Role of CYP2B6 pharmacogenomics in bupropion-mediated smoking cessation
    Andrew Xuan Vinh Tran, R COOPERDEHOFF, Sheeba Varghese Gupta · 2018 · Journal of Clinical Pharmacy and Therapeutics
  58. Administration of N-acetylcysteine Plus Acetylsalicylic Acid Markedly Inhibits Nicotine Reinstatement Following Chronic Oral Nicotine Intake in Female Rats
    Marı́a Elena Quintanilla, Paola Morales, Fernando E. Ezquer, Marcelo Ezquer, Mario Herrera‐Marschitz, Yedy Israel · 2021 · Frontiers in Behavioral Neuroscience
  59. Acute generalized exanthematous pustulosis caused by varenicline
    A Duparc, P. Gosset, J Caron, Audrey Lasek, P. Modiano · 2009 · Journal of the European Academy of Dermatology and Venereology
  60. Pregnancy Outcome after Varenicline Exposure in the First Trimester
    Yusuf Cem Kaplan, Nihal Olgaç Dündar, Burcu Kasap, Barış Karadas · 2014 · Case Reports in Obstetrics and Gynecology
  61. An efficient synthesis of varenicline
    Srinivas Pasikanti, Devarapu Srinivasa Reddy, B. Venkatesham, Praveen Kumar Dubey, Javed Iqbal M, Parthasarathi Das · 2009 · Tetrahedron Letters
  62. Varenicline is a smoking cessation drug that blocks alveolar expansion in mice intratracheally administrated porcine pancreatic elastase
    Mitsuhisa Koga, Yuki Kanaoka, Tetsushi Tashiro, Nagisa Hashidume, Yasufumi Kataoka, Atsushi Yamauchi · 2018 · Journal of Pharmacological Sciences
  63. More than Smoke and Patches: The Quest for Pharmacotherapies to Treat Tobacco Use Disorder
    Megan Jo Moerke, Lance Richard McMahon, Jenny L. Wilkerson · 2020 · Pharmacological Reviews
  64. Smoking Hazards and Cessation
    Neal L. Benowitz, Paul G. Brunetta · 2010 · Elsevier eBooks
  65. Nicotinic Acetylcholine Receptor Alterations in Autism Spectrum Disorders – Biomarkers and Therapeutic Targets
    René Anand, A. Stephanie, Gerald D. Ponath, Jordan I., Muhammad Ismail Nasir, B. Susan · 2011 · InTech eBooks
  66. A novel series of [3.2.1] azabicyclic biaryl ethers as α3β4 and α6/4β4 nicotinic receptor agonists
    John A. Lowe III, Shari L. DeNinno, Jotham W. Coe, Lei Zhang, Scot Mente, Raymond S Hurst, Robert J. Mather, Karen M. Ward, Alka Shrikhande, Hans Rollema et al. · 2010 · Bioorganic & Medicinal Chemistry Letters
  67. Maximizing Smoking Cessation in Clinical Practice: Pharmacologic and Behavioral Interventions
    Mitchell A. Nides, Scott James Leischow, Linda Sarna, Sarah E. Evans · 2007 · Preventive Cardiology
  68. Recent advances in gene manipulation and nicotinic acetylcholine receptor biology
    Anne Tammimäki, William J. Horton, Jerry A. Stitzel · 2011 · Biochemical Pharmacology
  69. The impact of three weeks of pre-quit varenicline on reinforcing value and craving for cigarettes in a laboratory choice procedure
    Schuyler C. Lawson, Julie C. Gass, Robert K. Cooper, Sarah Tonkin, Craig R. Colder, Martin Christopher Mahoney, Stephen T. Tiffany, Larry W. Hawk · 2020 · Psychopharmacology
  70. Iridium-catalysed synthesis of C,N,N-cyclic azomethine imines enables entry to unexplored nitrogen-rich 3D chemical space
    Yaseen A. Almehmadi, Jack McGeehan, Nandini J. Guzman, Kirsten E. Christensen, Ken Yamazaki, Darren J. Dixon · 2024 · Nature Synthesis
  71. Fatality following a suicidal overdose with varenicline
    Christophe Pol Stove, Els A. De Letter, Michel H A Piette, Willy E. Lambert · 2012 · International Journal of Legal Medicine
  72. Pharmacotherapy for tobacco cessation: Nicotine agonists, antagonists, and partial agonists
    Maher Karam‐Hage, Paul M. Cinciripini · 2007 · Current Oncology Reports
  73. Smoking Cessation Interventions for Lung Cancer Patients
    Kristin Carson‐Chahhoud, Zafar Ahmad Usmani, Thomas A. Robertson, Satya Mysore, Malcolm P Brinn · 2013 · Lung Cancer Management
  74. Current Treatment Options in Smoking Cessation
    Dominique Crain, Abid Bhat · 2010 · Hospital Practice
  75. Clinical experience of varenicline for smoking cessation
    Jae‐Woo Jung, Eun Ju Jeon, Jae Gyu Kim, Suh‐Yoon Yang, Jae Chol Choi, Jong Wook Shin, In Won Park, Byoung Whui Choi, Don‐Kyu Kim, Jae Yeol Kim · 2009 · The Clinical Respiratory Journal
  76. Immediate release tablet formulation of varenicline salicylate and comparative pharmacokinetic study in human volunteers
    Seong Shin Kwak, Eun Seok Lee, Ho Yub Yoon, Chang Hyun Kim, Yoon Tae Goo, Myung Joo Kang, Sang Kil Lee, Bong Sang Lee, Hong Ryeol Jeon, Chang Hyun Oh et al. · 2018 · Drug Design Development and Therapy
  77. New Rigid Nicotine Analogues, Carrying a Norbornane Moiety, Are Potent Agonists of α7 and α3* Nicotinic Receptors
    Dina Manetti, Aleksandra I. Garifulina, Gianluca Bartolucci, Carla Bazzicalupi, Cristina Bellucci, Niccolò Chiaramonte, Silvia Dei, Lorenzo Di Cesare Mannelli, Carla Ghelardini, Paola Gratteri et al. · 2019 · Journal of Medicinal Chemistry
  78. The effects of varenicline on methamphetamine self-administration and drug-primed reinstatement in male rats
    Steven T. Pittenger, Scott T. Barrett, Shinnyi Chou, Rick A. Bevins · 2016 · Behavioural Brain Research
  79. The influence of acute varenicline administration on smoking and eating behavior in humans
    William Walton Stoops, Andrea Rae Vansickel, Paul E.A. Glaser, Craig R. Rush · 2008 · Pharmacology Biochemistry and Behavior
  80. Improvement of Restless Legs Syndrome by Varenicline as Antismoking Treatment
    Andrea Romigi, Giuseppe Vitrani · 2013 · Journal of Clinical Sleep Medicine
  81. Stress Degradation Studies on Varenicline Tartrate and Development of a Validated Stability-Indicating HPLC Method
    Sudhakar S. Pujeri · 2011 · Scientia Pharmaceutica
  82. Varenicline improves motor and cognitive symptoms in early Huntington’s disease
    Ailsa L. McGregor, Jo Dysart, Malcolm Drummond Tingle, Bruce Russell, Robert R. Kydd, Gregory Finucane · 2016 · Neuropsychiatric Disease and Treatment
  83. Pseudo three-component approach to coumarin-annulated azepines: synthesis of coumarin[3,4-b]azepines
    Kiran B. Manjappa, Yu‐Ting Peng, Teau‐Jiuan Liou, Ding‐Yah Yang · 2017 · RSC Advances
  84. Natural products as tools for studies of ligand‐gated ion channels
    Kristian Strømgaard · 2005 · The Chemical Record
  85. Preparation of novel azabicyclic amines and α7 nicotinic acetylcholine receptor activity of derived aryl amides
    Daniel P. Walker, Brad A. Acker, E. Jon Jacobsen, Donn G. Wishka · 2008 · Journal of Heterocyclic Chemistry
  86. SMOKING AS A RISK FACTOR FOR CARDIOVASCULAR AND CEREBROVASCULAR DISEASES: PREVALENCE, IMPACT ON PROGNOSIS, POSSIBLE SMOKING CESSATION STRATEGIES AND THEIR EFFECTIVENESS. Part 2. Advantages of quitting smoking. Strategies to quit smoking
    Ol'ga Dmitrievna Ostroumova, Копченов Иван Иванович, Tatiana F. Guseva · 2018 · Rational Pharmacotherapy in Cardiology
  87. Año SEPAR 2007: Año para la Prevención y el Control del Tabaquismo
    Carlos Andrés Jiménez Ruiz, Ángela Ramos Pinedo, Juan Antonio Riesco Miranda, Julio Ancochea · 2007 · Archivos de Bronconeumología
  88. The Persistent Challenge of Developing Addiction Pharmacotherapies
    Sarah E. Swinford-Jackson, Charles P. O’Brien, Paul J. Kenny, Louk J. M. J. Vanderschuren, Ellen M. Unterwald, Robert Christopher Pierce · 2020 · Cold Spring Harbor Perspectives in Medicine
  89. The smoking cessation drug varenicline improves deficient P20–N40 inhibition in DBA/2 mice
    Kristin M. Wildeboer, Karen E. Stevens · 2011 · Pharmacology Biochemistry and Behavior
  90. Specificity of Varenicline in Blocking Mesolimbic Circuit Activation to Natural and Drug Rewards
    Nitsan Goldstein, Jamie R. E. Carty, J. Nicholas Betley · 2021 · Neuroscience
  91. Update on smoking cessation therapies
    Deirdre A. Glynn, John F. Cryan, Pauline Kent, Robert A. Flynn, Marcus Peter Kennedy · 2009 · Advances in Therapy
  92. Synthesis and Behavioral Studies of Chiral Cyclopropanes as Selective α4β2-Nicotinic Acetylcholine Receptor Partial Agonists Exhibiting an Antidepressant Profile. Part III
    Oluseye K. Onajole, Gian Paolo Vallerini, Jason Brek Eaton, Ronald J. Lukas, Dani Brunner, Barbara J. Caldarone, Alan P. Kozikowski · 2016 · ACS Chemical Neuroscience
  93. The effects of varenicline on lumbar spinal fusion in a rat model
    Jason R. Kang, Juliane D. Glaeser, Brian A. Karamian, Linda E.A. Kanim, Zachary M. NaPier, Jayme Carolynn Burket Koltsov, Timothy Thio, Khosrowdad Salehi, Hyun W. Bae, Ivan Cheng · 2019 · The Spine Journal
  94. Quantitative Molecular Imaging of Neuronal Nicotinic Acetylcholine Receptors in the Human Brain with A-85380 Radiotracers
    Shahrdad Lotfipour, Mark A. Mandelkern, Arthur L. Brody · 2011 · Current Medical Imaging Formerly Current Medical Imaging Reviews
  95. Computational studies of novel carbonyl-containing diazabicyclic ligands interacting with α4β2 nicotinic acetylcholine receptor (nAChR) reveal alternative binding modes
    David C. Kombo, Anatoly A. Mazurov, Jon‐Paul Strachan, Merouane Bencherif · 2013 · Bioorganic & Medicinal Chemistry Letters
  96. Update on the Pharmacologic Therapy for Chronic Obstructive Pulmonary Disease
    Nicola Alexander Hanania, Amir Sharafkhaneh · 2007 · Clinics in Chest Medicine
  97. Comparison of the Effectiveness of Varenicline, Extended-Release Bupropion and Nicotine Replacement Therapy on The Success and the Maintenance of a Smoking Cessation Program
    Selma Bozkurt Zincir, Serkan Zincir, Esra Kaymak, Esra Aydın Sünbül · 2013 · Klinik Psikofarmakoloji Bülteni-Bulletin of Clinical Psychopharmacology
  98. Partial agonists for α4β2 nicotinic receptors stimulate dopaminergic neuron firing with relatively enhanced maximal effects
    Ying Chen, Lisa M. Broad, Keith Geoffrey Phillips, Ruud Zwart · 2011 · British Journal of Pharmacology
  99. Randomized Clinical Trials Investigating Innovative Interventions for Smoking Cessation in the Last Decade
    Marie N. S. Gendy, Christine Ibrahim, Matthew E. Sloan, Bernard Le Foll · 2019 · Handbook of experimental pharmacology
  100. Nephrotoxic effects of varenicline as the most effective drug used for smoking cessation: a preliminary experimental study
    Akif Koç, Haydar Ali Erken, Fatma Emel Koçak, Arzu Yay, Aydın Güçlü, Erhan Sarı, Hasan Şimşek, Gözde Özge Önder, Osman Genç · 2015 · International Urology and Nephrology